European Medical Solutions
XBRU:ALEMS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
European Medical Solutions
XBRU:ALEMS
|
BE |
|
Conagra Brands Inc
NYSE:CAG
|
US |
|
Ethernity Networks Ltd
LSE:ENET
|
IL |
|
Wuxi Shangji Automation Co Ltd
SSE:603185
|
CN |
|
Grandjoy Holdings Group Co Ltd
SZSE:000031
|
CN |
|
T
|
Teleperformance SE
XBER:RCF
|
FR |
|
Sheffield Resources Ltd
ASX:SFX
|
AU |
|
E
|
Etga Group Ltd
TASE:ETGA
|
IL |
|
C
|
CombinedX AB (publ)
F:K13
|
SE |
|
T
|
Truong Thanh Furniture Corp
VN:TTF
|
VN |
|
Asia Financial Holdings Ltd
HKEX:662
|
HK |
|
M
|
Modulight Oyj
OMXH:MODU
|
FI |
|
Yu Tak International Holdings Ltd
HKEX:8048
|
HK |
|
Marksans Pharma Ltd
NSE:MARKSANS
|
IN |
|
Agesa Hayat ve Emeklilik AS
IST:AGESA.E
|
TR |
|
Coronado Global Resources Inc
ASX:CRN
|
AU |
|
A
|
ACDC Metals Ltd
ASX:ADC
|
AU |
Bankruptcy Probability
European Medical Solutions's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
European Medical Solutions Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BE |
|
European Medical Solutions
XBRU:ALEMS
|
22.8m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
380.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
190.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
174.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
68.5B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
39.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
European Medical Solutions's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, European Medical Solutions has total debt of 13.7m EUR. This includes both short-term (4m EUR) and long-term (9.7m EUR) debt.
You can find a full breakdown on its Balance Sheet.
